World’s First Respiratory Syncytial Virus Vaccine Approved: All About The Virus And Vaccine
[ad_1] The US Food and Drug Administration (FDA) on Wednesday, May 3, 2023, approved the world’s first respiratory syncytial virus vaccine. The vaccine, called Arexvy, is manufactured by British pharmaceutical company GSK, and has been approved for use in individuals aged 60 years and above in the United States. Arexvy is an adjuvanted respiratory syncytial … Read more